By Philips ∙ May 12 2025 ∙ Duration 4:13
Ultimately, UMCG chose to partner with Philips to implement a secure, state-of-the-art patient monitoring solution, supported by a Patient Monitoring Informatics Services Agreement (PMISA), a customized software maintenance service contract that provides A central part of PMISA is PerformanceBridge Focal Point, a centralized operational management solution that enables IT and BioMeds to monitor solution uptime and track performance.
At the heart of PMISA is a commitment to deliver high-quality care. We support healthcare professionals by helping them focus on patient care, rather than the equipment – allowing more time at the bedside.
Watch how UMC Groningen’s clinicians benefit from this partnership and see how a customized patient monitoring solution could help your organization achieve the same success.
Head of Medical Technology, University Medical Center Groningen
[1] Lawton J. et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. JACC. 2022;79(2):e21-e129. [2] Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59. [3] 2018 ESC/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;00:1-96. Japan guidelines [4] Jeremias A et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 Oct 28;12(20):1991-2001. [5] Patel M., et al. 1-Year outcomes of blinded physiological assessment of residual ischemia after successful PCI. JACC Cardiol Interv. 2022;15(1):52-61. [6] FDA 510k (#K173860). The iFR modality is intended to be used in conjunction with currently marketed Philips pressure wires. In the coronary anatomy, the iFR modality has a diagnostic cut-point of 0.89 which represents an ischemic threshold and can reliably guide revascularization decisions during diagnostic catheterization procedure. [7] Gotberg M. et al. iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI. Late-breaking clinical Trial presentation at TCT on November 4, 2021.
You are about to visit a Philips global content page
Continue